CRISPR

In the Lab By Associated Press

Lab tests show risks of using CRISPR gene editing on embryos

Biotech By Adam Feuerstein

CRISPR Therapeutics’ CAR-T treatment shows encouraging results, but one death is tied to therapy

First Opinion By Patrick Skerrett

The CRISPR Nobel was about more than two women scientists. It was about all of them

In the Lab By Andrew Joseph

The CRISPR story: How a basic research discovery changed science and led to a Nobel

Health By Matthew Herper

Jennifer Doudna, now a Nobel winner, on CRISPR and its role in medical research

First Opinion By Josephine Johnston

The U.S. must do some heavy lifting to prepare for heritable genome editing

Health By Andrew Joseph

Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’

In the Lab By Gideon Gil

Virtual Event: CRISPR’s forward march

In the Lab By Sharon Begley

Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases

In the Lab By Sharon Begley

In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys

Biotech By Jonathan Saltzman — Boston Globe

Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease

First Opinion By Matthias Evers and Michael Chui

The Bio Revolution is changing business and society

Biotech By Sharon Begley

Deluge of genome editing therapies ends research drought for sickle cell disease

Health By Sharon Begley

New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say

Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein

‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film

First Opinion By Neal Baer

Covid-19 is scary. Could a rogue scientist use CRISPR to conjure another pandemic?

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Biotech By Jonathan Saltzman — Boston Globe

Beam Therapeutics raises $180 million in IPO

In the Lab By Sharon Begley

DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola

First Opinion By Josephine Johnston

He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?

Don't Miss By STAT staff

What will 2020 bring for medicine and science? We asked 16 leaders for predictions

In the Lab By Sharon Begley

Creating Pig3.0, the world’s most CRISPR’d animal, raises hopes of transplantable organs

Biotech By Sharon Begley and Adam Feuerstein

First CRISPR treatment for blood diseases shows early benefits in two patients

In the Lab By Sharon Begley

You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers